US46116X1019 - Common Stock
INTRA-CELLULAR THERAPIES INC
NASDAQ:ITCI (4/25/2024, 3:30:02 PM)
After market: 72.13 0 (0%)72.13
-0.99 (-1.35%)
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 561 full-time employees. The company went IPO on 2014-01-31. The firm is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company’s product CAPLYTA is a treatment for depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults as monotherapy and as adjunctive therapy with lithium or valproate. The efficacy of CAPLYTA 42 mg in bipolar depression was demonstrated in two positive Phase III placebo-controlled bipolar depression studies, which evaluated the effects of CAPLYTA on depression in adult patients with bipolar I or bipolar II disorder both as monotherapy (Study 404) and as adjunctive therapy with lithium or valproate (Study 402).
INTRA-CELLULAR THERAPIES INC
430 East 29th Street, Suite 900
New York City NEW YORK 10016
P: 16464409333
CEO: Sharon Mates
Employees: 561
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company...
These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in biotech stocks is not for the faint of heart. The sector is prone ...
The Nasdaq and S&P 500 tumbled below their 50-day lines.
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company...
Here you can normally see the latest stock twits on ITCI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: